Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: news events pd l1 testing results lung cancer
Medical Technologies Chart a complete course to commercial success. Identifying an unmet need in the market and meeting regulatory requirements is only half of the commercialization picture. All too often we see manufacturers focus on the regulatory …
… have collaborated with our clients on projects to research cancer, cancer treatment, and complications and comorbidities of … neck cancer Large B-cell lymphoma Leukemia Liver cancer Lung cancer Melanoma Myelofibrosis Neuroendocrine tumors …
… Mond T, Marshall G, Sweeney C, Davenport E, Wang J. @AANP_NEWS #AANP23 …
Instrument Development In accordance with regulatory guidelines and expectations in the US and Europe, we can help you develop new COAs and modify existing measures to support your product approval and labeling claims. We also identify and develop COAs to …
International Symposium on Merkel Cell Carcinoma (ISMCC 2022) Share on: Monday, April 25, 2022 Conference Website Research coauthored by RTI-Health Solutions researcher Alejandro Vanegas will be presented at the International Symposium on Merkel Cell …
… The specific challenges associated with data analysis from cancer studies. Why safety and patient-reported outcome endpoints may appear contradictory in cancer trials. Why traditional statistical methods for clinical trials can lead to biased results when applied to oncology studies. Possible analytic …
14th Annual Sentinel Initiative Public Workshop Share on: Tuesday, November 15 - Wednesday, November 16, 2022 Event webpage Bradley Layton, PhD, Director, Epidemiology at RTI Health Solutions is giving a presentation at the 14th Annual Sentinel …
Josephine Mauskopf Recognized by ISPOR For Extraordinary Leadership Share on: April 16, 2019 The International Society for Pharmacoeconomics and Outcomes Research ( ISPOR ) announced yesterday that it had recognized Josephine Mauskopf, PhD, Vice …
… evidence related to your research questions—whether the results will be used to inform your drug development and … search protocol to conducting the search and reviewing the results, our rigorous, quality-controlled processes … clinical development programs. Incidence of adverse events among a patient population or those taking a certain …
… its post-market commitments. These moves were based on results from 18 years of epidemiologic research conducted by … research. Throughout the US, RTI-HS worked with 45 state cancer registries and several comprehensive cancer … N, Andrews EB . Long-term cancer surveillance: results from the Forteo Patient Registry Surveillance Study . …